These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25597310)

  • 1. Role of LAT1 in the promotion of amino acid incorporation in activated T cells.
    Hayashi K; Anzai N
    Crit Rev Immunol; 2014; 34(6):467-79. PubMed ID: 25597310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic mysteries of the inflammatory response: T cell polarization and plasticity.
    Fracchia KM; Walsh CM
    Int Rev Immunol; 2015 Jan; 34(1):3-18. PubMed ID: 25398050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells.
    Hayashi K; Jutabha P; Endou H; Sagara H; Anzai N
    J Immunol; 2013 Oct; 191(8):4080-5. PubMed ID: 24038088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular metabolism on T-cell development and function.
    Chen H; Yang T; Zhu L; Zhao Y
    Int Rev Immunol; 2015 Jan; 34(1):19-33. PubMed ID: 24708060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-acid transporters in T-cell activation and differentiation.
    Ren W; Liu G; Yin J; Tan B; Wu G; Bazer FW; Peng Y; Yin Y
    Cell Death Dis; 2017 Mar; 8(3):e2655. PubMed ID: 28252650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-type amino acid transporter 1 (LAT1)-specific inhibitor is effective against T cell-mediated nasal hyperresponsiveness.
    Kaminuma O; Nishimura T; Saeki M; Yamasaki N; Ogata S; Fujita T; Endou H; Hayashi K
    Allergol Int; 2020 Jul; 69(3):455-458. PubMed ID: 31928946
    [No Abstract]   [Full Text] [Related]  

  • 7. L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy.
    Hayashi K; Anzai N
    J Pharmacol Sci; 2022 Jan; 148(1):31-40. PubMed ID: 34924127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation.
    Nii T; Segawa H; Taketani Y; Tani Y; Ohkido M; Kishida S; Ito M; Endou H; Kanai Y; Takeda E; Miyamoto Ki
    Biochem J; 2001 Sep; 358(Pt 3):693-704. PubMed ID: 11535130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling.
    Nagamori S; Wiriyasermkul P; Okuda S; Kojima N; Hari Y; Kiyonaka S; Mori Y; Tominaga H; Ohgaki R; Kanai Y
    Amino Acids; 2016 Apr; 48(4):1045-1058. PubMed ID: 26724922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
    Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J
    Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer.
    Salisbury TB; Arthur S
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
    Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
    Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
    Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival.
    Maciver NJ; Jacobs SR; Wieman HL; Wofford JA; Coloff JL; Rathmell JC
    J Leukoc Biol; 2008 Oct; 84(4):949-57. PubMed ID: 18577716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.
    Siska PJ; van der Windt GJ; Kishton RJ; Cohen S; Eisner W; MacIver NJ; Kater AP; Weinberg JB; Rathmell JC
    J Immunol; 2016 Sep; 197(6):2532-40. PubMed ID: 27511728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
    Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
    Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation.
    Venet F; Demaret J; Blaise BJ; Rouget C; Girardot T; Idealisoa E; Rimmelé T; Mallet F; Lepape A; Textoris J; Monneret G
    J Immunol; 2017 Sep; 199(5):1606-1615. PubMed ID: 28724580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter.
    Napolitano L; Scalise M; Galluccio M; Pochini L; Albanese LM; Indiveri C
    Int J Biochem Cell Biol; 2015 Oct; 67():25-33. PubMed ID: 26256001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of immune cells.
    Faris M; Bot A
    Int Rev Immunol; 2015 Jan; 34(1):1-2. PubMed ID: 25591070
    [No Abstract]   [Full Text] [Related]  

  • 20. Developmental regulation of the rabbit blood-brain barrier LAT1 large neutral amino acid transporter mRNA and protein.
    Boado RJ; Li JY; Pardridge WM
    Pediatr Res; 2004 Apr; 55(4):557-60. PubMed ID: 14764922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.